State of Michigan Retirement System Cuts Stake in Cabot Co. (NYSE:CBT)

State of Michigan Retirement System lessened its holdings in Cabot Co. (NYSE:CBTFree Report) by 2.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,265 shares of the specialty chemicals company’s stock after selling 300 shares during the quarter. State of Michigan Retirement System’s holdings in Cabot were worth $1,219,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in CBT. California Public Employees Retirement System lifted its stake in shares of Cabot by 2.3% in the 4th quarter. California Public Employees Retirement System now owns 96,712 shares of the specialty chemicals company’s stock valued at $8,075,000 after acquiring an additional 2,206 shares during the last quarter. GAMMA Investing LLC bought a new stake in Cabot in the fourth quarter valued at approximately $44,000. Russell Investments Group Ltd. boosted its stake in shares of Cabot by 20.4% during the fourth quarter. Russell Investments Group Ltd. now owns 28,319 shares of the specialty chemicals company’s stock valued at $2,365,000 after purchasing an additional 4,801 shares during the period. Hexagon Capital Partners LLC grew its holdings in shares of Cabot by 81.8% in the fourth quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 207 shares during the last quarter. Finally, Victory Capital Management Inc. increased its stake in shares of Cabot by 90.2% in the fourth quarter. Victory Capital Management Inc. now owns 156,113 shares of the specialty chemicals company’s stock worth $13,035,000 after buying an additional 74,023 shares during the period. 93.18% of the stock is owned by institutional investors.

Insider Activity

In related news, CFO Erica Mclaughlin sold 23,274 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the completion of the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $5,968,839.06. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CFO Erica Mclaughlin sold 23,274 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares in the company, valued at approximately $5,968,839.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Jeff Ji Zhu sold 1,201 shares of Cabot stock in a transaction on Monday, August 26th. The shares were sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now owns 96,000 shares of the company’s stock, valued at approximately $10,194,240. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 46,322 shares of company stock worth $4,707,405. Corporate insiders own 3.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CBT shares. StockNews.com cut shares of Cabot from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 24th. JPMorgan Chase & Co. increased their target price on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. UBS Group reduced their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Finally, Mizuho increased their price objective on Cabot from $104.00 to $109.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $101.75.

Check Out Our Latest Research Report on CBT

Cabot Price Performance

Shares of NYSE CBT opened at $104.26 on Friday. Cabot Co. has a 1 year low of $65.10 and a 1 year high of $106.92. The stock has a market capitalization of $5.76 billion, a P/E ratio of 13.20, a P/E/G ratio of 0.96 and a beta of 1.20. The company’s 50-day moving average is $96.26 and its 200 day moving average is $94.18. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.24 and a quick ratio of 1.47.

Cabot (NYSE:CBTGet Free Report) last posted its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. Cabot had a return on equity of 26.21% and a net margin of 11.51%. The business’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.42 EPS. On average, sell-side analysts expect that Cabot Co. will post 6.78 earnings per share for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 30th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.65%. The ex-dividend date is Friday, August 30th. Cabot’s dividend payout ratio is currently 21.77%.

About Cabot

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.